Janssen Reports First Results from Phase 2 SunRISe-1 Study of TAR-200 and Anti- PD-1 Antibody Cetrelimab in Patients with Bacillus Calmette-Gu érin-Unresponsive Non-Muscle-Invasive Bladder Cancer
CHICAGO, April 30, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from the open-label Phase 2 SunRISe-1 study evaluating the efficacy and safety of TAR-200 monotherapy (a novel investigational intravesical drug delivery system) and cetrelimab monotherapy (an investigational anti-PD-1 monoclonal antibody administered intravenously) in patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (HR-NMIBC), who are ineligible for, or decline, radical cystectomy. The study demonstrated that 72.7 percent of patients treated wit...
Source: Johnson and Johnson - April 30, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Trial Casts Shadow on Photodynamic Surgery for Bladder Cancer Trial Casts Shadow on Photodynamic Surgery for Bladder Cancer
Photodynamic diagnosis-guided TURBT did not reduce 3-year recurrence rates of non –muscle-invasive bladder cancer in a real-world trial compared with white light-guided cystoscopy.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 15, 2023 Category: Pathology Tags: Hematology-Oncology News Source Type: news
Episode 6: Non-Muscle Invasive Bladder Cancer Innovations Episode 6: Non-Muscle Invasive Bladder Cancer Innovations
Drs Cheryl Lee and Sima Porten discuss urinary biomarkers, enhanced cystoscopy, treatments on the horizon, and communication with team members from the cytopathology lab using PARIS classification.Medscape (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 8, 2022 Category: Pathology Tags: Urology InDiscussion Source Type: news
FDA Approves Bludigo (indigotindisulfonate sodium) for Cystoscopic Assessment of the Ureters Following Urological and Gynecological Surgical Procedures
Marseille, France and Collegeville, PA, USA– July 12, 2022– Provepharm, a French company specialized in the development of pharmaceutical applications, today announces that it has received FDA New Drug Approval for the marketing of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 12, 2022 Category: Drugs & Pharmacology Source Type: news
Drastic Drop in Antibiotic Overuse for Common Urology Procedure: How They Did It
(MedPage Today) -- NEW ORLEANS -- Using a tool to classify patients' infection risk and providing education and systems-level changes in the urology department safely reduced prophylactic antibiotic use around cystoscopy, according to a single... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 16, 2022 Category: Infectious Diseases Source Type: news
More Evidence That Pandemic Delayed Cancer Diagnoses
A recent study finds fewer procedures to diagnose cancer were done over the past 2 years, including cystoscopies to detect bladder cancer. (Source: WebMD Health)
Source: WebMD Health - February 9, 2022 Category: Consumer Health News Source Type: news
Costs and profitability of cystoscopy depend on number of procedures performed
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 1, 2021 Category: Drugs & Pharmacology Source Type: news
FDA Clearance of the Uro-G Completes UroViu Corporation's Suite of Portable, Single-Use, Disposable Cystoscopes
The Devices Revolutionize Cystoscopy by Eliminating Reprocessing, Capital Investment, Servicing, and Advance Scheduling
LOS ALTOS, Calif., May 24, 2021 -- (Healthcare Sales & Marketing Network) -- UroViu Corporation, the developer of a suite of portabl... Devices, Urology, FDA UroViu , Uro-G, single-use cystoscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2021 Category: Pharmaceuticals Source Type: news
Low Diagnostic Yield With Cystoscopy and CT Urography for Urinary Tract Cancers Low Diagnostic Yield With Cystoscopy and CT Urography for Urinary Tract Cancers
Few patients with microhematuria who undergo evaluation for urinary tract cancers with cystoscopy or CT urography are diagnosed with a malignancy, a systematic review and meta-analysis suggests.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 12, 2021 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Up-and-coming NC medical firm seeks buyer in wake of product launch
A Raleigh-based medical device company focused on women's health is actively seeking a buyer after closing its Series C fund raise.
UVision 360 raised $3.5 million in equity mostly from investors in the southeastern part of the country, according to a recent securities filing. UVision developed and commercialized the Luminelle hysteroscopy system, which received U.S. Food and Drug clearance in 2018. The system allows doctors t o conduct hysteroscopies and cystoscopies in a gynecologist's office instead… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 10, 2021 Category: American Health Authors: Sonia Waraich Source Type: news
Up-and-coming medical firm in Raleigh seeks buyer in wake of product launch
A Raleigh-based medical device company focused on women's health is actively seeking a buyer after closing its Series C fund raise.
UVision 360 raised $3.5 million in equity mostly from investors in the southeastern part of the country, according to a recent securities filing. UVision developed and commercialized the Luminelle hysteroscopy system, which received U.S. Food and Drug clearance in 2018. The system allows doctors t o conduct hysteroscopies and cystoscopies in a gynecologist's office instead… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2021 Category: Biotechnology Authors: Sonia Waraich Source Type: news
Up-and-coming medical firm in Raleigh seeks buyer in wake of product launch
A Raleigh-based medical device company focused on women's health is actively seeking a buyer after closing its Series C fund raise.
UVision 360 raised $3.5 million in equity mostly from investors in the southeastern part of the country, according to a recent securities filing. UVision developed and commercialized the Luminelle hysteroscopy system, which received U.S. Food and Drug clearance in 2018. The system allows doctors t o conduct hysteroscopies and cystoscopies in a gynecologist's office instead… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 7, 2021 Category: American Health Authors: Sonia Waraich Source Type: news
Former Beaumont Employees and Medical Device Distributor Charged with Wire Fraud for a Scheme to Steal Medical Devices
FDA OCI, Paul Purdy, Beavercreek OH, Valdet Seferovic, Auburn Hills MI, Zafar Khan, Fenton MI, wire fraud, medical devices, steal, medical supplies, Beaumont Hospital, cystoscopes, contaminated, ophthalmoscopes, otoscopes, internet, sold, Wholesale Medical& Surgical Suppliers of America, indictmen (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - January 15, 2021 Category: Medical Law Authors: DOJ Source Type: news
Cystoscopy Training For Advanced Practice Urology Providers Cystoscopy Training For Advanced Practice Urology Providers
This article provides standardized recommendations for the training of advanced practice providers in cystoscopy.Urologic Nursing (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 5, 2020 Category: Consumer Health News Tags: Urology Journal Article Source Type: news
Upstate shines light on bladder cancer
Blue Light Cystoscopy helps doctors better detect and diagnose cancerous tumors in the bladder. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - August 23, 2019 Category: Universities & Medical Training Source Type: news
